Report Company Directory
- Monthly LMI Update Independent Investment Research by Independent Investment Research
- Feasibility Study Results in December to be a Catalyst for this Junior by Fundamental Research
- FATE: 3Q18 Update: Flush With Cash – Readouts at SITC and ASH by Raymond James
- The Law Offices of Vincent Wong Reminds Investors of an Investigation of Juno Therapeutics, Inc. in Connection with the Sale of the Company to Celgene Corp. by BusinessWire
- INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Juno Therapeutics, Inc. to Celgene Corp. is Fair to Shareholders by BusinessWire
- JUNO THERAPEUTICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Celgene Corporation May be Unfair to Shareholders by BusinessWire
- JUNO THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout by BusinessWire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Juno Therapeutics, Inc. to Celgene Corp. is Fair to Shareholders by BusinessWire
- JUNO THERAPEUTICS INVESTIGATION by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO by BusinessWire
- A director sold after exercising options/sold 270,250 shares at 46.174USD and by SmartInsider